Federal health officials at the Food and Drugs Administration have given the go-ahead on an innovative heart valve from medical device producers, Medtronic that can be implanted without the tremendous risk of open-heart surgery.
The FDA approved Medtronic’s Melody Pulmonary Valve, a device for individuals of all ages afflicted with a heart defect that threatens the flow of blood between the heart's right chambers and lungs.
The Melody Pulmonary Valve is a welcome change to current technologies, which are both dangerous and invasive. Current valves, inserted through Open Heart Surgery, break down with the years, requiring repeated open-heart procedures to maintain them. Alternatively, the new development is implanted using a less disruptive catheter inserted through an incision in the leg.
Congenital heart defects affect members of the population of all ages and continue to be the most common global birth defect.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription
